Physical activity before and after exercise in women with chronic fatigue syndrome

We measured physical activity after strenuous exercise in 20 women with chronic fatigue syndrome (CFS), compared to 20 sedentary healthy volunteers who exercised no more than once per week. Activity was measured for 2 weeks using a portable waist-worn vertical accelerometer. After the first week of activity monitoring, all participants returned for a maximal treadmill test, followed by continued activity monitoring for the second week. Five activity measures were derived from the data: (i) average activity; (ii) total activity; (iii) duration of waking day; (iv) duration; and (v) number of daily rests. A repeated measures ANCOVA was used to determine post- treadmill group differences accounting for pre-treadmill differences. There was a significant reduction in overall average activity after the treadmill test, with the greatest decrease on days 12 through 14. This reduction was accompanied by a significant increase in the duration of the waking day and number of daily rests. Thus, marked exertion does produce changes in activity, but later than self-report would suggest, and are apparently not so severe that CFS patients cannot compensate.      

Thrombotic microangiopathy associated with cryoglobulinemic membranoproliferative glomerulonephritis and hepatitis C

Cryoglobulinemic membranoproliferative glomerulonephritis (MPGN) and increased incidence of vascular thromboses are complications of hepatitis C virus (HCV) infection. This report describes the clinical, laboratory, and renal biopsy findings in two HCV-positive patients with cryoglobulinemic MPGN and thrombotic microangiopathy (TMA). Testing for circulating antiphospholipid antibodies, which are detected in a significant proportion of patients with HCV, was negative in the one case in which it was done. This article discusses the possible cause of the TMA in these two cases.     

Analysis of N-ras gene mutation and p53 gene expression in human hepatocellular carcinomas

ＡｎａｌｙｓｉｓｏｆＮｒａｓｇｅｎｅｍｕｔａｔｉｏｎａｎｄｐ５３ｇｅｎｅｅｘｐｒｅｓｓｉｏｎｉｎｈｕｍａｎｈｅｐａｔｏｃｅｌｕｌａｒｃａｒｃｉｎｏｍａｓＬＵＯＤａｎ１，ＬＩＵＱｉＦｕ１，ＣＧｏｖｅ２，ＮＶＮａｏｍｏｖ２，ＳＵＪｉａｎＪｉａ１ａ...